DataKnowledgeCloudtrainingcoordination

COL Q9H4I2-1 GLY 000517 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)

Protein:

ZHX3 HUMAN

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Compound:

N-ACETYL-beta-D-GLUCOSAMINE

Compound (Entity type)

Collection:

human proteoform glycosylation sites oglcnac mcw.csv

File (Entity type)

Description:Information for protein Q9H4I2-1 in the context of file GLY_000517

Creation Time:2026-03-02 19:57:25.000000

Results found

Linked to

	Label	Description
	ZHX3 HUMAN Protein (Entity type)	Zinc fingers and homeoboxes protein 3
	q9h4i2-1 586thr 586thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9h4i2-1 735thr 735thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9h4i2-1 591thr 591thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9h4i2-1 596thr 596thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9h4i2-1 246ser 246ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9h4i2-1 243ser 243ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9h4i2-1 593thr 593thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9h4i2-1 240ser 240ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9h4i2-1 231ser 231ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

Protein

ZHX3 HUMAN

Protein (Entity type)

Zinc fingers and homeoboxes protein 3

Post Translational Modification

q9h4i2-1 586thr 586thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9h4i2-1 735thr 735thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9h4i2-1 591thr 591thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9h4i2-1 596thr 596thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9h4i2-1 246ser 246ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9h4i2-1 243ser 243ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9h4i2-1 593thr 593thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9h4i2-1 240ser 240ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9h4i2-1 231ser 231ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.